Last $0.84 USD
Change Today +0.0883 / 11.77%
Volume 200.0
MTST On Other Exchanges
Symbol
Exchange
OTC US
As of 12:03 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

metastat inc (MTST) Snapshot

Open
$0.84
Previous Close
$0.75
Day High
$0.84
Day Low
$0.84
52 Week High
02/24/14 - $1.92
52 Week Low
09/4/14 - $0.50
Market Cap
22.4M
Average Volume 10 Days
15.8K
EPS TTM
$-0.18
Shares Outstanding
26.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for METASTAT INC (MTST)

Related News

No related news articles were found.

metastat inc (MTST) Related Businessweek News

No Related Businessweek News Found

metastat inc (MTST) Details

MetaStat, Inc., a life sciences company, focuses on developing and commercializing novel diagnostic technologies and therapeutics for prediction and treatment of systemic metastasis. Its MetaSite Breast and MenaCalc diagnostic product lines are designed to predict the probability of cancer metastasizing. These are intended to allow clinicians to customize cancer treatment decisions by identifying and differentiating high-risk patients who need aggressive therapy and by sparing low-risk patients from the harmful side effects and expense of chemotherapy and radiation therapies. The company’s MenaCalc diagnostic platform is also applicable in solid epithelial-based cancers, including breast, prostate, lung, and colorectal. In addition, it is developing therapeutic programs that understand the mena biology and alternative splicing events as drivers of disease progression, which allows identifying novel targets and develop new classes of chemotherapy. Metastat, Inc. is based in Montclair, New Jersey.

6 Employees
Last Reported Date: 06/13/14

metastat inc (MTST) Top Compensated Officers

Chief Executive Officer, Chief Medical Office...
Total Annual Compensation: $194.2K
Founder, President, Chief Financial Officer, ...
Total Annual Compensation: $175.0K
Vice President of Finance and Controller
Total Annual Compensation: $137.0K
Compensation as of Fiscal Year 2014.

metastat inc (MTST) Key Developments

MetaStat, Inc. Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-12-2014 01:00 PM

MetaStat, Inc. Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-12-2014 01:00 PM. Venue: The Encore at Wynn Las Vegas, 3121 Las Vegas Blvd. South, Las Vegas, NV 89109, United States. Speakers: Oscar M. Bronsther, Chief Executive Officer, Chief Medical Officer and Director.

MetaStat, Inc. Presents at Rodman & Renshaw 16th Annual Global Investment Conference, Sep-10-2014 02:05 PM

MetaStat, Inc. Presents at Rodman & Renshaw 16th Annual Global Investment Conference, Sep-10-2014 02:05 PM. Venue: New York Palace Hotel – 455 Madison Avenue, New York, NY 10022, United States. Speakers: Oscar M. Bronsther, Chief Executive Officer, Chief Medical Officer and Director.

MetaStat, Inc. announced delayed annual 10-K filing

On 05/28/2014, MetaStat, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MTST:US $0.84 USD +0.0883

MTST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MTST.
View Industry Companies
 

Industry Analysis

MTST

Industry Average

Valuation MTST Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact METASTAT INC, please visit www.metastat.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.